Mounjaro

News

Lilly goes toe-to-toe with Novo Nordisk on obesity

Eli Lilly has raised the stakes in its looming battle with Novo Nordisk in the market for obesity drugs, planning a clinical trial that will directly compare its new thera

News

Lilly injects $450m into plant making Mounjaro

Eli Lilly is leaving nothing to chance when it comes to making the most of its fast-growing diabetes therapy Mounjaro – it is investing another $450million at a facility in North Carolina t

News

Lilly says Mounjaro launch is "viral in nature"

One of the highlights of Eli Lilly's third-quarter results was the rapid uptake of new type 2 diabetes therapy Mounjaro, which added more than $97 million in US sales alone in what has been

Views & Analysis

Lilly’s Mounjaro wins latest head-to-head battle in clinical...

Diabetes is one of the most common health conditions in the United States, afflicting more than 11% of the population, with over 90% included in the type 2 category.

News

Roche's fast-growing eye drug Vabysmo set for EU approval

Roche has been trumpeting the rapid uptake of its new eye disease drug Vabysmo as it takes on Regeneron and Bayer's mighty Eylea in the US – and could soon start making inroads against its

News

Lilly’s new drug Mounjaro (tirzepatide ) wins US FDA approva...

Blood sugar control drug Mounjaro has been granted US regulatory approval, giving type 2 diabetics another way to help keep their glucose levels in check.

Lilly goes toe-to-toe with Novo Nordisk on obesity

Lilly injects $450m into plant making Mounjaro

Lilly says Mounjaro launch is "viral in nature"

Lilly’s Mounjaro wins latest head-to-head battle in clinical...

Roche's fast-growing eye drug Vabysmo set for EU approval

Lilly’s new drug Mounjaro (tirzepatide ) wins US FDA approva...

Kyverna rises on stiff person syndrome data

How to meet your physicians where they are online

Mounjaro

Editor's Picks